Chromosome Bandings and Recognition.
C-banding
Chromosome analysis
Chromosome banding
G-banding
R-banding
Journal
Methods in molecular biology (Clifton, N.J.)
ISSN: 1940-6029
Titre abrégé: Methods Mol Biol
Pays: United States
ID NLM: 9214969
Informations de publication
Date de publication:
2024
2024
Historique:
medline:
24
6
2024
pubmed:
24
6
2024
entrez:
24
6
2024
Statut:
ppublish
Résumé
Chromosome banding can be defined as the lengthwise variation in staining properties along a chromosome stained with a dye. Chromosome banding became more practical in the early 1970s and is an essential technique used in karyotyping to identify human chromosomes for both clinical and research purposes. Most importantly, karyotyping is now considered a mandatory investigation of all newly diagnosed leukemias. Some banding methods, such as Giemsa (G)-, reverse (R)-, and centromere (C)-banding, still contribute greatly by being used as a routine procedure in clinical cytogenetic laboratory nowadays. Each chromosome has a unique sequence of bar code-like stripes, allowing the identification of individual homologues and the recognition of structural abnormalities through analyzing the disruption of the normal banding pattern at specific landmarks, regions, and bands as described in the ideogram. Since the quality of metaphases obtained from malignant cells is generally inferior to normal constitutional cells for karyotyping, a practical and accurate chromosome identification training guide is indispensable for a trainee or newly employed cytogenetic technologist in a cancer cytogenetic laboratory. The most common and currently used banding methods and chromosome recognition guide for distinguishable bands of each chromosome are described in detail in this chapter with an aim to facilitate quick and accurate karyotyping in cancer cells.
Identifiants
pubmed: 38913307
doi: 10.1007/978-1-0716-3946-7_7
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
137-150Informations de copyright
© 2024. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Ushiki T, Hoshi O, Iwai K et al (2002) The structure of human metaphase chromosomes: its histological perspective and new horizons by atomic force microscopy. Arch Histol Cytol 65(5):377–390
doi: 10.1679/aohc.65.377
pubmed: 12680454
Niimura Y, Gojobori T (2002) In silico chromosome staining: reconstruction of Giemsa bands from the whole human genome sequence. Proc Natl Acad Sci USA 99:797–802
doi: 10.1073/pnas.022437999
pubmed: 11792839
pmcid: 117385
Furey TS, Haussler D (2003) Integration of the cytogenetic map with the draft human genome sequence. Hum Mol Genet 12:1037–1044
doi: 10.1093/hmg/ddg113
pubmed: 12700172
Craig JM, Bickmore WA (1993) Chromosome bands—flavours to savour. BioEssays 15:349–354
doi: 10.1002/bies.950150510
pubmed: 8343145
Francke U (1994) Digitized and differentially shaded human chromosome ideograms for genomic applications. Cytogenet Cell Genet 65(3):206–218
doi: 10.1159/000133633
pubmed: 8222762
Verma RS, Lubs HA (1976) A simple R banding technique. Am J Hum Genet 27:110–117
Sumner AT (1972) A simple technique for demonstrating centromeric heterochromatin. Exp Cell Res 75:304–306
doi: 10.1016/0014-4827(72)90558-7
pubmed: 4117921
McGowan-Jordan J, Hastings RJ, Moore S (eds) (2020) ISCN(2020): an international system for human Cytogenomic nomenclature. S. Karger, Basel
Yunis JJ (1981) Mid-prophase human chromosomes: the attainment of 2000 bands. Hum Genet 56:293–298
doi: 10.1007/BF00274682
pubmed: 7239513
Casperson T, Zech L, Johansson C (1970) Differential binding of alkylating fluorochromosomes in human chromosomes. Exp Cell Res 60:315–319
doi: 10.1016/0014-4827(70)90523-9
Paris Conference (1971) Standardization in human cytogenetics (1972). Cytogenetics 11:317–362
Wan TS (2014) Cancer cytogenetics: methodology revisited. Ann Lab Med 34:413–425
doi: 10.3343/alm.2014.34.6.413
pubmed: 25368816
pmcid: 4215412
Wan TS, Ma SK, Chan LC (2000) Acquired pericentric inversion of chromosome 9 in essential thrombocythemia. Hum Genet 106:669–670
doi: 10.1007/s004390050041
pubmed: 10942117